Fulgent Genetics, Inc. (NASDAQ: FLGT) reported Q1 EPS of ($0.22), $0.30 better than the analyst estimate of ($0.52). Revenue for the quarter came in at $66.2 million versus the consensus estimate of $59.62 million.

For earnings history and earnings-related data on Fulgent Genetics, Inc. (FLGT) click here.